Kettering General Hospital, Rothwell Road, Kettering, NN16 8UZ, UK.
Siloam Hospitals Lippo Village - Universitas Pelita Harapan, Tangerang, Indonesia.
Curr Cardiol Rep. 2024 Jun;26(6):497-503. doi: 10.1007/s11886-024-02064-z. Epub 2024 May 9.
This review aimed to collate the available evidence on outcomes following routine functional stress testing vs standard of care (i.e. symptom-guided stress testing) in high-risk patients following percutaneous coronary intervention (PCI).
The most recent pragmatic POST-PCI trial provided randomized evidence showing that routine functional stress testing post-PCI did not lead to a reduction in 2-year ischemic cardiovascular events or all-cause mortality, as compared to a symptom-guided standard-of-care approach. This was also true for sub-analyses including multivessel or left main disease, diabetics, as well as following imaging or physiology guided PCI. In the absence of a change in their clinical or functional status suggestive of stent failure, post-PCI routine periodic stress testing in stable patients on guideline-directed medical therapy is currently not recommended by American clinical practice guidelines. While evidence on the cost-effectiveness of routine stress testing strategy is scarce, physician, payer, and policy-level interventions to reduce inappropriate use of routine functional testing need to be addressed.
本综述旨在整理经皮冠状动脉介入治疗(PCI)后高危患者进行常规功能压力测试与标准治疗(即症状指导的压力测试)相比的结局相关证据。
最近一项实用的 POST-PCI 试验提供了随机证据,表明与症状指导的标准治疗方法相比,PCI 后常规功能压力测试并未降低 2 年缺血性心血管事件或全因死亡率。对于包括多血管或左主干疾病、糖尿病患者以及影像学或生理学指导的 PCI 后进行的亚分析也是如此。在没有提示支架失败的临床或功能状态变化的情况下,目前美国临床实践指南不建议对接受指南指导的药物治疗的稳定型患者进行 PCI 后的常规定期压力测试。虽然关于常规压力测试策略的成本效益的证据很少,但需要解决医生、支付方和政策层面的干预措施,以减少常规功能测试的不当使用。